These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7677962

  • 1. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
    Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC.
    JAMA; 1993 Jan 06; 269(1):57-60. PubMed ID: 7677962
    [Abstract] [Full Text] [Related]

  • 2. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, Sullivan LD.
    Urology; 1996 May 06; 47(5):708-12. PubMed ID: 8650870
    [Abstract] [Full Text] [Related]

  • 3. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
    Huncharek M, Muscat J.
    Cancer Invest; 1995 May 06; 13(1):31-5. PubMed ID: 7530590
    [Abstract] [Full Text] [Related]

  • 4. Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications.
    Oesterling JE.
    Urol Clin North Am; 1993 Nov 06; 20(4):705-11. PubMed ID: 7505979
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA, Valenzuela H, Morote J, Gelabert A.
    Eur J Nucl Med; 1999 Jun 06; 26(6):625-32. PubMed ID: 10369948
    [Abstract] [Full Text] [Related]

  • 10. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
    Al-Ghazo MA, Ghalayini IF, Al-Azab RS, Bani-Hani I, Barham A, Haddad Y.
    Int Braz J Urol; 2010 Jun 06; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
    [Abstract] [Full Text] [Related]

  • 11. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
    Kageyama Y, Kihara K, Kamata S, Nagahama K, Yonese J, Fukuda H, Tosaka A, Nagamatsu H, Ishizaka K, Tsujii T, Kitahara S, Morita T, Oshima H.
    Hinyokika Kiyo; 1996 Mar 06; 42(3):197-9. PubMed ID: 8619388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The relationship between the serum level of prostate specific antigen and bone and CT scans in the staging of the primary carcinoma of the prostate].
    Hoefman E, Hulshof MC, de Reijke TM, Bruijnes E, Redekop WK, van Straalen JP.
    Ned Tijdschr Geneeskd; 1998 May 16; 142(20):1142-6. PubMed ID: 9623236
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?
    Vijayakumar V, Vijayakumar S, Quadri SF, Blend MJ.
    Am J Clin Oncol; 1994 Oct 16; 17(5):432-6. PubMed ID: 7522394
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Using prostate-specific antigen to eliminate the staging radionuclide bone scan.
    Lee CT, Oesterling JE.
    Urol Clin North Am; 1997 May 16; 24(2):389-94. PubMed ID: 9126236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.